10-K: Mentor Capital Reports 2024 Results, Divests Legacy Investment, and Focuses on Energy Sector

Mentor Capital, Inc. divested its facilities operations segment and is focusing on acquisitions and investments in the classic energy markets, reporting a net loss for 2024.

Summary

• Mentor Capital, Inc. reported a net loss attributable to Mentor of ($839,505) or ($0.036) per Mentor common share for the year ended December 31, 2024, compared to a net gain of $3,157,658 or $0.137 per Mentor common share for the year ended December 31, 2023.
• The company sold its majority ownership interest in Waste Consolidators, Inc. (WCI) on October 4, 2023, resulting in a gain of $4,805,389 and the elimination of the facilities operations segment.
• Mentor is focusing on expanding into operating segments of the classic energy markets of oil, gas, coal, uranium, and related markets.
• The company's selling, general, and administrative expenses decreased by $994,998 to $780,212 for the year ended December 31, 2024.
• As of December 31, 2024, Mentor had cash of $2,182,121 and working capital of $3,263,848.
• The company repurchased 3,000,000 shares of its common stock for $183,993 during 2024.
• Mentor is pursuing collection of a $2,539,597 judgment against G Farma Settlors, with the judgment and interest receivable fully reserved.
• The company's future success depends on its ability to generate positive cash flow from acquisitions and investments and to obtain sufficient capital from non-portfolio-related sources.

Sentiment

Score: 4

Explanation: The document presents a mixed picture. While the company divested a legacy investment and is focusing on a new sector, it reported a net loss and has a significant accumulated deficit. The future outlook is uncertain, and the company faces several risks.

Positives

• The sale of WCI provided the company with capital to seek out new business opportunities in the classic energy space.
• Selling, general, and administrative expenses decreased significantly in 2024.
• The company has a significant amount of cash and working capital.
• The company is actively pursuing collection of a judgment against G Farma Settlors.
• The company has a plan to raise additional capital through the sale of equity securities and debt.

Negatives

• The company reported a net loss of ($839,505) for 2024.
• The company has a significant accumulated deficit of ($9,027,312) as of December 31, 2024.
• The company is dependent on its ability to make a return on its acquisitions and investments to generate positive cash flow.
• The company is pursuing collection of a $2,539,597 judgment against G Farma Settlors, with the judgment and interest receivable fully reserved.

Risks

• The company's future financial condition may be materially and adversely impacted as a result of the ongoing worldwide economic, political, and military situations.
• The company may face difficulties in securing additional financing in the energy sector.
• The company's success is dependent on its ability to make a return on its acquisitions and investments to generate positive cash flow.
• The company is dependent on its key personnel, and the loss of Mr. Billingsley could have a material adverse effect on the business and prospects.
• The company's Common Stock is not listed on any exchange and trades on the OTC Markets OTCQB system, and the market for the stock is limited.

Future Outlook

The company will continue to look for acquisition opportunities to expand its portfolio, ideally with companies that are positive for operating revenue or have the potential to become positive for operating revenue.

Management Comments

• Management believes they can raise additional funds to support their business plan and develop a successful operating company.
• Management anticipates funding new activities by raising additional capital through the sale of equity securities and debt.
• Management believes that securing substantial additional sources of financing is possible, but there is no assurance of our ability to secure such financing.

Industry Context

The company is shifting its focus to the classic energy markets, which may be subject to heightened scrutiny and additional regulations.

Comparison to Industry Standards

• The company's investment in six New York Stock Exchange energy companies in the oil and gas, coal, uranium, and pipeline markets equaled approximately 68.16% of the Companys market capitalization at December 31, 2024.
• The company's strategy of investing in small businesses is similar to that of other venture capital firms, but the company's focus on the classic energy markets is more specific.
• The company's decision to exit the cancer immunotherapy sector is consistent with the challenges faced by other companies in that industry due to government limitations on reimbursement for highly technical and expensive cancer treatments.

Management Changes

Legal Proceedings

• The Company is pursuing collection of a $2,539,597 judgment against G Farma Settlors.

Stakeholder Impact

• Shareholders may experience dilution following exercise of warrants for cash.
• The company's involvement in the classic energy sector may draw political or regulatory scrutiny.

Next Steps

• The company will continue to look for acquisition opportunities to expand its portfolio.
• The company will seek to raise additional funds through financing, additional collaborative relationships, or other arrangements to increase revenues to support positive cash flow.

Key Dates

Keywords

energy, acquisitions, investments, waste consolidators, financial results, mentor capital, warrants, oil, gas, coal, uranium